intervention for treating Persistent Depressive disorder in children and adolescents. 2. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug? 3. Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Question Answered step-by-step 1. Recommend one FDA-approved drug, one off-label drug, and one nonpharmacologicalintervention for treating Persistent Depressive disorder in children and adolescents. 2. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug? 3. Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration. Health Science Science Nursing NRNP 6665 Share QuestionEmailCopy link Comments (0)


